Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Effectiveness of Daratumumab in Combination with Lenalidomide and Dexamethasone (DRd) Vs. Common Standard-of-Care Regimens in Patients with Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM)

Brian G.M. Durie, MD, Shaji K. Kumar, MD, Saad Z. Usmani, MD, Bareng A.S. Nonyane, Eric A. Ammann, Annette Lam, Rachel Kobos, MD, Eric M Maiese, PhD, Thierry Facon, MD

Blood (2019) 134 (Supplement_1): 1830.

https://doi.org/10.1182/blood-2019-122937

Published: 2019

Journal Articles

Reinforcement Learning to Optimize the Treatment of Multiple Myeloma

Kenneth H. Shain, MD PhD, Daniel Hart, Ariosto Siqueira Silva, PhD, Raghunandanreddy Alugubelli, MS, Gabriel De Avila, BS, Praneeth Reddy Sudalagunta, PhD, Alexandre Tungesvik, MD, Amit Kulkarni, PhD, Carmelo Blancuicett, PhD MD, Hongyue Dai, PhD, Taiga Nishihori, MD, Jason B. Brayer, PhDMD, Brandon Blue, MD, Melissa Alsina, MD, Rachid Baz, MD, William S. Dalton, PhDMD

Blood (2019) 134 (Supplement_1): 5511.

https://doi.org/10.1182/blood-2019-132234

Published: 2019

Journal Articles

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Irina Demmer, Susanne Huschens, Dietrich Potthoff, Jörg Tomeczkowski, Christian Englisch, Pushpike Thilakarathne, Joris Diels, Shaji K. Kumar, MD, Brian GM Durie, MD, Lewin Eisele

Blood (2018) 132 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2018-99-116884

Published: 2018

Journal Articles

Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia

Julie Olson, PhD, Joanne S. Buzaglo, PhD, Shauna McManus, BS, Linda House, RN, BSN, MSM, Thomas W. LeBlanc, MD MA

Blood (2018) 132 (Supplement 1): 5870.

https://doi.org/10.1182/blood-2018-99-118996

Published: 2018

Journal Articles

Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials

Blood (2017) 130 (Supplement 1): 744.

https://doi.org/10.1182/blood.V130.Suppl_1.744.744

Published: 2017

Journal Articles

The Leeds Risk Profile Predicts Outcome for Older Myeloma Patients: A Prognostic Score Using Frailty Biomarkers Derived and Tested Using 2371 Clinical Trial Patients

Gordon Cook, MD PhD, Kara-Louise Royle, Charlotte Pawlyn, BA,PhDMBBChir,MRCP,FRCPath, Anna Hockaday, Walter M Gregory, PhD, J Anthony Child, Faith E Davies, MD, Gareth J. Morgan, MD PhD, David Cairns, BSc, MSc, PhD, Graham Jackson, MDPhD

Blood (2017) 130 (Supplement 1): 3063.

https://doi.org/10.1182/blood.V130.Suppl_1.3063.3063

Published: 2017

Journal Articles

Predictors of Quality of Life, Dyspnea, and Walking Distance during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Extended Results of the E.L.O.P.E. Study

Susan R. Kahn, MD, Arash Akaberi, MSc, Andrew M Hirsch, MD, John T Granton, MD

Blood (2016) 128 (22): 3530.

https://doi.org/10.1182/blood.V128.22.3530.3530

Published: 2016

Journal Articles

Incidence, Risk Factors and Outcome of Late Onset Noninfectious Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study

Anne Bergeron, MD PhD, Sylvie Chevret, MD PhD, Regis Peffault De La Tour, MD PhD, Karine Chagnon, MD, Cedric De Bazelaire, MD PhD, Frédéric Rivière, MD, Marie Robin, MD PhD, Jean Mani, MD, Gwenael Lorillon, MD, Socié Gérard, MD PhD, Abdellatif Tazi, MD PhD

Blood (2016) 128 (22): 4562.

https://doi.org/10.1182/blood.V128.22.4562.4562

Published: 2016

Journal Articles

Clinical Application of Artificial Intelligence in Patients with Chronic Myeloid Leukemia in Chronic Phase

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Susan O'Brien, MD, Farhad Ravandi, MD, Marina Konopleva, MDPhD, Gautam Borthakur, MD, William G. Wierda, MD PhD, Naval Daver, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Jeffrey Skinner, Mary Beth Rios, RN, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 940.

https://doi.org/10.1182/blood.V128.22.940.940

Published: 2016

Journal Articles

The Immunogenicity of Red Blood Cell Antigens in Relation to Antigen Exposure

Dorothea Evers, MD, Rutger Middelburg, PhD, Masja De Haas, Prof, MD, Saurabh Zalpuri, MD PhD, Karen de Vooght, PhD, Daan van de Kerkhof, PhD, Otto Visser, MD PhD, Nathalie Pequeriaux, Francisca Hudig, PhD, Henk Schonewille, PhD, Jaap Jan Zwaginga, MD PhD, Anske van der Bom, MD PhD

Blood (2015) 126 (23): 1139.

https://doi.org/10.1182/blood.V126.23.1139.1139

Published: 2015

Journal Articles

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Stefan Deneberg, MD, PhD, Ebba Lundin, Vladimir Lazarevic, Lina Benson, Bertil Uggla, MDPhD, Petar Antunovic, MD, Lars Mollgard, Sören Lehmann, Prof, Gunnar Juliusson, MD PhD, Martin Höglund, Ass Prof, Asa Rangert Derolf, MDPhD

Blood (2015) 126 (23): 3748.

https://doi.org/10.1182/blood.V126.23.3748.3748

Published: 2015

Journal Articles

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Nick van Es, MD, Suzanne Bleker, MD, Ankie Kleinjan, MDPhD, Rene Berckmans, PhD, J W Wilmink, MDPhD, Rienk Nieuwland, PhD, Saskia Middeldorp, MD PhD, Harry R Büller, MD PhD

Blood (2014) 124 (21): 4250.

https://doi.org/10.1182/blood.V124.21.4250.4250

Published: 2014

Journal Articles

Low Pre-Transplant Levels of 25-Hydroxyvitamin D3 Predict Relapse and Survival in Male but Not in Female Patients Undergoing Allogeneic Stem Cell Transplantation

Aleksandar Radujkovic, MD, Axel Benner, Sascha Dietrich, MD, Ute Hegenbart, MD, Stefan O Schönland, Anthony D. Ho, MD FRCPC, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 1181.

https://doi.org/10.1182/blood.V124.21.1181.1181

Published: 2014

Journal Articles

HLA Is a Determinant Of The Ethnic Predisposition Of Chronic Lymphocytic Leukemia

LOREN GRAGERT, Stephanie DiPrima, Mark Albrecht, Martin Maiers, Matt Kalaycio, MD, Brian T. Hill, MD, PhD

Blood (2013) 122 (21): 1620.

https://doi.org/10.1182/blood.V122.21.1620.1620

Published: 2013

Journal Articles

Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Stephanie J. Lee, MD, MPH, Jennifer Le Rademacher, PhD, Heather Jim, PhD, Karen L Syrjala, PhD, John R. Wingard, MD, PhD, Brent R. Logan, PhD, Juan Wu, MS, Navneet S. Majhail, MD, MS, William A. Wood, MD, MPH, J. Douglas Rizzo, MD, Nancy L. Geller, PhD, Carrie L. Kitko, MD, Edward A. Faber, Jr., DO, MS, Muneer H. Abidi, MD, Susan E. Slater, FNP, Mary M. Horowitz, MD, MS, Paul Jacobsen, Ph.D.

Blood (2013) 122 (21): 699.

https://doi.org/10.1182/blood.V122.21.699.699

Published: 2013

Journal Articles

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

Blood (2013) 122 (21): 362.

https://doi.org/10.1182/blood.V122.21.362.362

Published: 2013

Journal Articles

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Mousami Shah, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm, D, Bety Ciobanu, MD, Rosalind Catchatourian, MD

Blood (2009) 114 (22): 4757.

https://doi.org/10.1182/blood.V114.22.4757.4757

Published: 2009

Journal Articles

Response of Patients with Aggressive Non Hodgkin's Gastro Intestinal Tract Lymphoma to Upfront Rituximab Based Chemotherapy: A Single Institution Experience.

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Mousami Shah, Barbara Yim, Pharm, D, Rosalind Catchatourian, MD

Blood (2009) 114 (22): 4791.

https://doi.org/10.1182/blood.V114.22.4791.4791

Published: 2009

NARROW

Effectiveness of Daratumumab in Combination with Lenalidomide and Dexamethasone (DRd) Vs. Common Standard-of-Care Regimens in Patients with Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM)

Reinforcement Learning to Optimize the Treatment of Multiple Myeloma

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia

Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials

The Leeds Risk Profile Predicts Outcome for Older Myeloma Patients: A Prognostic Score Using Frailty Biomarkers Derived and Tested Using 2371 Clinical Trial Patients

Predictors of Quality of Life, Dyspnea, and Walking Distance during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Extended Results of the E.L.O.P.E. Study

Incidence, Risk Factors and Outcome of Late Onset Noninfectious Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study

Clinical Application of Artificial Intelligence in Patients with Chronic Myeloid Leukemia in Chronic Phase

The Immunogenicity of Red Blood Cell Antigens in Relation to Antigen Exposure

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Low Pre-Transplant Levels of 25-Hydroxyvitamin D3 Predict Relapse and Survival in Male but Not in Female Patients Undergoing Allogeneic Stem Cell Transplantation

HLA Is a Determinant Of The Ethnic Predisposition Of Chronic Lymphocytic Leukemia

Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Response of Patients with Aggressive Non Hodgkin's Gastro Intestinal Tract Lymphoma to Upfront Rituximab Based Chemotherapy: A Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only